Pulmonary Segmentectomy for Lung Cancer: A Real-World International Registry-TSOG 108
Trial Status: active
This study creates a patient registry of people who have surgery for lung cancer.
Inclusion Criteria
- * Age ≥ 18 years * Clinical Stage I with suspected NSCLC, classified preoperatively based on the AJCC TNM staging manual, 9th edition. ** Note: Tissue diagnosis of NSCLC is not required before enrollment. A pathologic diagnosis of NSCLC may be confirmed preoperatively with biopsy, intraoperatively with frozen section, or postoperatively on final pathology
Exclusion Criteria
- * Actively receiving lung cancer treatment or a history of lung cancer in the previous 5 years * History of chemotherapy or radiation therapy for a previous lung cancer * Synchronous primaries or secondary cancer in the lung or elsewhere in the body at the time of surgery * Carcinoid tumors * History of other malignancies within the past 3 years, with the exception of nonmelanoma skin cancer, superficial bladder cancer, hematogenous malignancies, and carcinoma in situ of the cervix * Actively receiving treatment for other malignancies * Cases of lobectomy in conjunction with segmentectomy from another lobe and ≥ 2 segmentectomies from different lobes either en bloc or separate will be excluded from the primary analysis. ** Multi-segmental resection from the same lobe is not a criterion for exclusion
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06424327.
Locations matching your search criteria
United States
Illinois
Chicago
Rush MD Anderson Cancer Center
Status: Active
Contact: Christopher William Seder
Phone: 312-942-6642
Email: christopher_w_seder@rush.edu
Evanston
NorthShore University HealthSystem-Evanston Hospital
Status: Active
Contact: Seth B. Krantz
Email: skrantz@northshore.org
Michigan
Ann Arbor
University of Michigan Rogel Cancer Center
Status: Active
Contact: Jules Lin
Phone: 734-763-0470
Email: juleslin@umich.edu
New Jersey
Basking Ridge
Memorial Sloan Kettering Basking Ridge
Status: Active
Contact: David R. Jones
Phone: 212-639-6428
Middletown
Memorial Sloan Kettering Monmouth
Status: Active
Contact: David R. Jones
Phone: 212-639-6428
Montvale
Memorial Sloan Kettering Bergen
Status: Active
Contact: David R. Jones
Phone: 212-639-6428
New York
Commack
Memorial Sloan Kettering Commack
Status: Active
Contact: David R. Jones
Phone: 212-639-6428
New York
Memorial Sloan Kettering Cancer Center
Status: Active
Contact: David R. Jones
Phone: 212-639-6428
Uniondale
Memorial Sloan Kettering Nassau
Status: Active
Contact: David R. Jones
Phone: 212-639-6428
West Harrison
Memorial Sloan Kettering Westchester
Status: Active
Contact: David R. Jones
Phone: 212-639-6428
Pennsylvania
Philadelphia
Thomas Jefferson University Hospital
Status: Active
Contact: Nathaniel Rutherford Evans
Pittsburgh
Allegheny General Hospital
Status: Active
Contact: Benny Weksler
Phone: 412-359-6137
Email: benny.weksler@ahn.org
Texas
Houston
M D Anderson Cancer Center
Status: Active
Contact: David Christopher Rice
Phone: 713-563-9148
Email: drice@mdanderson.org
PRIMARY OBJECTIVE:
I. Determine 3- and 5-year DFS among patients undergoing pulmonary segmentectomy for lung cancer.
OUTLINE: This is an observational study.
Patients complete questionnaires before standard of care surgery, between 2 to 4 weeks after surgery, and 6 months after surgery and have their medical records reviewed on study.
Trial PhaseNo phase specified
Trial TypeNot provided by clinicaltrials.gov
Lead OrganizationMemorial Sloan Kettering Cancer Center
Principal InvestigatorDavid R. Jones
- Primary ID24-127
- Secondary IDsNCI-2024-04609
- ClinicalTrials.gov IDNCT06424327